Salix Pharmaceuticals (SLXP): Q4 EPS of $0.81 beats by $0.03. Revenue of $198.1M misses by...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q4 EPS of $0.81 beats by $0.03. Revenue of $198.1M misses by $1.31M. (PR)